Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: TN, United States

: | OTC Markets: PVCT

Similar to: AstraZeneca Plc, Wuxi PharmaTech Inc., Hutchison China MediTech Ltd.

Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company, which specializes in developing oncology and dermatology therapies. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The company's dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed its Phase 2 trials of PV-10 and of PH-10. Provectus Biopharmaceuticals was founded on May 1, 1978 and is headquartered in Knoxville, TN.

News & Analysis

You may also be interested in: